SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001600620-24-000051
Filing Date
2024-05-02
Accepted
2024-05-02 06:07:28
Documents
92
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20240331.htm   iXBRL 10-Q 882797
2 EX-3.4 vknappertzseveranceagreeme.htm EX-3.4 50100
3 EX-31.1 auph-2024q1exx311.htm EX-31.1 10866
4 EX-31.2 auph-2024q1exx312.htm EX-31.2 11008
5 EX-32.1 auph-2024q1exx321.htm EX-32.1 5334
6 EX-32.2 auph-2024q1exx322.htm EX-32.2 5342
12 image_0a.jpg GRAPHIC 11140
13 image_9a.jpg GRAPHIC 130
  Complete submission text file 0001600620-24-000051.txt   5947415

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20240331.xsd EX-101.SCH 46176
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20240331_cal.xml EX-101.CAL 74919
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20240331_def.xml EX-101.DEF 180862
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20240331_lab.xml EX-101.LAB 515800
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20240331_pre.xml EX-101.PRE 368982
95 EXTRACTED XBRL INSTANCE DOCUMENT auph-20240331_htm.xml XML 824450
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 24905056
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)